A gastric tumor is considered HER2‐positive if scored as IHC 3+ based on a surgical specimen exhibiting strong complete, basolateral, or lateral membranous reactivity in ≥10% of tumor cells. The gene discussed is ERBB2; the disease is gastric neoplasm.